Revenue Growth
Q4 2025 revenue grew 6% year-over-year to $522.3M; full-year 2025 revenue increased 8% year-over-year to $1,910.0M.
Ex-TAC Gross Profit Expansion
Full-year ex-TAC gross profit was approximately $713.5M, up 7% year-over-year; Q4 ex-TAC gross profit was $212.8M with ~41% ex-TAC margin.
Free Cash Flow and Conversion
Generated $163.4M in free cash flow for 2025, up 10% year-over-year, representing approximately 76% conversion from adjusted EBITDA (company notes a sustainable free cash flow conversion expectation of 60%-70% over a typical four-quarter period).
Adjusted EBITDA and Margins
Company reiterated target of 30% adjusted EBITDA margin; management reported adjusted EBITDA growth (CEO cited +7%) and CFO reported full-year adjusted EBITDA of $215.5M (30% margin on reported basis).
Realize Platform Traction
Realize contributed to measurable advertiser expansion: scaled advertisers grew 6% for the year (3% in Q4) and average revenue per scaled advertiser grew 2%; Realize drove testing among non-scaled advertisers (contributed ~1% to Q4 growth).
Notable ICP Wins and Opportunity
Personal finance example: $120M in personal finance revenue in 2025 within a $15B US addressable market; company estimates it captures only 1%-10% of advertisers' total spend, signaling meaningful runway.
Share Repurchases and Capital Return
Repurchased ~76.9M–77.0M shares in 2025 for ~ $250M–$254M; reduced total shares outstanding from ~337M to ~276M (management cited roughly an 18% reduction in share count; company also noted it bought back ~8% of outstanding shares net of issuances in 2025).
Strong Cash & Liquidity Position
Ended Q4 2025 with cash and cash equivalents of $120.9M, net cash of ~$18.6M after long-term debt of $102.3M; secured a $270M revolving credit facility and had approximately $168M of available liquidity as of Dec 31, 2025.
Forward Guidance Reflects Continued Growth
FY2026 guidance includes ex-TAC gross profit of $753M–$774M (implying ~7% growth vs. 2025 ex-TAC midpoint), adjusted EBITDA guidance of $222M–$236M, and continued focus on R&D and share repurchases.